ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,303, issued on Oct. 7, was assigned to Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany).

"Continuous flow reactor for low pH viral inactivation" was invented by Stephanie Parker (Rialto, Calif.), Cameron Lee Bardliving (Claremont, Calif.), Jonathan Coffman (Gaithersbury, Calif.), Scott Godfrey (Pleasanton, Calif.) and Raquel Orozco (Richmond, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A viral inactivation device including at least one continuous viral inactivation reactor having an inlet, an outlet, and a tubular flow path. The tubular flow path includes a set of alternating turns that form a serpentine pattern between...